Title

FoxO1 調節抗胰島素激素基因的表現

Translated Titles

FoxO1 regulates resistin gene expression

Authors

錢葉盛

Key Words

抗胰島素激素 ; resistin ; FoxO1

PublicationName

中央大學生命科學系學位論文

Volume or Term/Year and Month of Publication

2008年

Academic Degree Category

碩士

Advisor

高永旭

Content Language

繁體中文

Chinese Abstract

抗胰島素激素(Resistin)為一種已知的脂肪細胞所分泌的細胞激素, 它會造成胰島素抗性作用,並扮演著調節能量平衡的角色。之前的文獻中已經找出許多會去調節resistin基因表現的轉錄因子以及其結合位﹐但是其調控機制仍然不清楚。FoxO1 (Forkhead/winged helix box gene,group O-1) 轉錄因子會受到胰島素調控將其磷酸化﹐去決定是否能在細胞核內作用。之前的研究中指出FoxO1與resistin隨著脂肪細胞分化的程度越好,兩者基因在脂肪細胞內皆會有改變﹐而FoxO1參與調控一些胰島素所調控的基因表現。胰島素又會抑制抗胰島素機速基因的表現。因此本論文假設FoxO1轉錄因子會參與脂肪細胞內抗胰島素激素基因表現的調控作用﹐實驗結果證明﹕(1) FoxO1,3,4與resistin 基因之表現確實在脂肪細胞分化的過程中,逐步升高。(2)轉染FoxO1-AAA與human resistin promoter(-819~+24 bp)在HEK 293T細胞株中。發現FoxO1隨著劑量增加而有負調控該啟動子的活性。 (3) 轉染FoxO1-AAA與human resistin promoter(-819~+24 bp)在NIH 3T3細胞株中。發現FoxO1隨著劑量增加而有負調控該啟動子的活性。由以上結果顯示,Foxo1調節human resistin promoter(-819~+24 bp)活性,不會因轉染細胞株不同而有差異性。 (4)FoxO1-AAA與以架構的三種(-3880~-55 bp,-1330~-55 bp,-990~-55 bp)共同轉染到HEK 293T細胞內,發現FoxO1-AAA均負調節三種mouse resistin promoter的活性。(5)野生型FoxO1,突變型FoxO1-AAA,以及FoxO1-H215R,分別與Human resistin promoter(-819~+24 bp)共同轉染到HEK 293,HEK 293T,或3T3細胞株中。皆發現是負調控該promoter活性。所以顯示FoxO1是間接性調控resistin promoter的活性。綜合以上的結果得知,FoxO1是負調節Human resistin promoter的活性。因為FoxO1-AAA與mouse resistin promoter共同轉染到 3T3細胞株中,FoxO1-AAA正調節該promoter 的活性(採自於學妹楊淑雅的實驗數據),所以FoxO1調節mouse resistin promoter的活性會因轉染不同細胞株而有所差異。

English Abstract

Resistin is also known as adipocyte secreted factor (ADSF) that plays potential role in insulin resistiance and homeostasis. Although resistin can be regulated by transcriptional factors, the action mechanism is still not clear. FoxO1 (Forkhead/winged helix box gene,group O-1) is a member of a family of nuclear transcriptional factors that can be regulated by insulin. It has been reported that FoxO1 and resistin genes express during adipocyte differentiation, and are negatively regulated by insulin. In this thesis,the hypothesis that FoxO1 regulates resistin gene expression was examined. The results were as follows. First, expression of FoxO1, FoxO3, FoxO4, and resistin genes were increased as 3T3-L1 adipocyte differentiation proceeded. Second, cotransfection of FoxO1-AAA with human resistin promoter (-819~+24) to HEK 293 or 293T cells indicated that FoxO1-AAA dose-dependently inhibited activity of human resistin promoter. Third, cotransfection of FoxO1-AAA with human resistin promoter (-819~+24) to NIH 3T3 cells indicated that FoxO1-AAA does-dependently inhibited activity of human resistin promoter. These results suggest the cell type-independent effect of FoxO1-AAA on human resistin promoter. Fourth, cotransfection of FoxO1-AAA with mouse resistin promoter (-3546~+165 bp, -1145~+165 bp, -805~+165 bp) to HEK 293 or 293T cells showed a downregulatory effect of FoxO1-AAA on mouse resistin promoter. Finally, both the wild type of FoxO1 and the mutant types of FoxO1-AAA and FoxO1-H215R downregulated human resistin promoter activity, indicating an indirect effect of FoxO1 on resistin gene. Taken together, FoxO1 downregulates human resistin promoter activity. Because FoxO1-AAA upregulated mouse resistin promoter activity in 3T3 cells, FoxO1 may regulate mouse resistin promoter activity in the cell type-dependent manner (adapted from susu).

Topic Category 理學院 > 生命科學系
生物農學 > 生物科學
Reference
  1. 2. Asensio, C., Cettour-Rose, P., Theander-Carrillo, C., Rohner-Jeanrenaud, F. and Muzzin, P. Changes in glycemia by leptin administration or high-fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology. 145: 2206–2213, 2004.
    連結:
  2. 3. Degawa-Yamauchi MBJE, Juliar BE, Watson W, Kerr K, Jones RM, Zhu Q & Considine RV. Serum resistin (FIZZ3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism. 88: 5452–5455, 2003.
    連結:
  3. 4. Lee, J. H., Bullen, Jr, J. W., Stoyneva, V. L. and Mantzoros, C. S. Circulating resistin in lean, obese and insulin-resistant mouse models: lack of association with insulinemia and glycemia. Am. J. Physiol. Endocrinol. Metab. 288: E625–E632, 2005.
    連結:
  4. 5. James C. Engert,1* Marie-Claude Vohl,2,3* Scott M. Williams,1,4* Pierre Lepage,1 J C. Loredo-Osti,5 5_ Flanking Variants of Resistin Are Associated With Obesity DIABETES, VOL. 51, MAY ,2002
    連結:
  5. 6. Na-Ping Tang*, Lian-Sheng Wang†, Li Yang‡, Bo Zhou*, Hai-Juan Gu*, Qing-Min Sun*, Ri-Hong Cong*,Huai-Jun Zhu* and Bin Wang* A polymorphism in the resistin gene promoter and the risk ofcoronary artery disease in a Chinese populationClinical Endocrinology ,2007
    連結:
  6. 7. Steve R. Smith, Fulu Bai, Chantal Charbonneau, Lenka Janderova´ , and George Argyropoulos A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance DIABETES, VOL. 52, JULY ,2003
    連結:
  7. 8. Jong Bae Seo, Mun Ju Noh, Eung Jae Yoo, So Yun Park, Jiyoung Park, In Kyu Lee, Sang Dai Park and Jae Bum Kim Functional Characterization of the Human Resistin Promoter with Adipocyte Determination- and Differentiation- Dependent Factor 1/Sterol Regulatory Element Binding Protein 1c and CCAAT Enhancer Binding Protein- Molecular Endocrinology, 2003
    連結:
  8. 9. Chung SS, Choi HH, Cho YM, Lee HK, Park KS. Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes Biochem Biophys Res Commun., 2006
    連結:
  9. 10. Gui Y, Silha JV, Mishra S, Murphy LJ. Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance. Can J Physiol Pharmacol. 2003
    連結:
  10. 11. Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA. Mechanisms regulating adipocyte expression of resistin J Biol Chem. 2002
    連結:
  11. 12. K.C. Choi a, S.Y. Lee a, H.J. Yoo a, O.H. Ryu a, K.W. Lee a, S.M. Kim b,S.H. Baik a, K.M. Choi a,* Effect of PPAR-d agonist on the expression of visfatin, adiponectin,and resistin in rat adipose tissue and 3T3-L1 adipocytes Biochemical and Biophysical Research Communications ,2007
    連結:
  12. 13. Zhenyu Xuan, Michael Q. Zhang* From worm to human: bioinformatics approaches to identify FOXO target genes Mechanisms of Ageing and Development ,2005
    連結:
  13. 14. Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression Oncogene. 2005
    連結:
  14. 15. Lehmann OJ, Sowden JC, Carlsson P, Jordan T, Bhattacharya SS. Fox''s in development and disease Trends Genet. 2003
    連結:
  15. 16. Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics. 1998
    連結:
  16. 17. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ 3rd, Emanuel BS, Rovera G, Barr FG. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genetics ,1993
    連結:
  17. 18. Tran H, Brunet A, Griffith EC, Greenberg ME. The many forks in FOXO''s road. Science Signaling.2003
    連結:
  18. 19. Cantley LC. The phosphoinositide 3-kinase pathway Science. 2002
    連結:
  19. 20. Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A. 1999
    連結:
  20. 21. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell. 1999
    連結:
  21. 22. Nakae J, Park BC, Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem. 1999
    連結:
  22. 23. Rena G, Guo S, Cichy SC, Unterman TG, Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem. 1999
    連結:
  23. 24. Tang ED, Nuñez G, Barr FG, Guan KL. Negative regulation of the forkhead transcription factor FKHR by Akt J Biol Chem. 1999
    連結:
  24. 25. Michihiro Matsumoto, Seongah Han, Tadahiro Kitamura, and Domenico Accili Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism The Journal of Clinical Investigation ,2006
    連結:
  25. 26. Hiroshi Onuma, Beth T. Vander Kooi, Jared N. Boustead, James K. Oeser, and Richard M. O’Brien Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) Binding and the Inhibition of Basal Glucose-6-Phosphatase Catalytic Subunit Gene Transcription by Insulin Molecular Endocrinology,2006
    連結:
  26. 27. Caroline M. McKinnon, Magalie A. Ravier, and Guy A. Rutter1 FoxO1 Is Required for the Regulation of Preproglucagon Gene Expression by Insulin in Pancreatic TC1–9 Cells* the journal of biological chemistry ,2006
    連結:
  27. 29. Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism Trends Endocrinol Metab. Review 2005
    連結:
  28. 30. Nakae J, Kitamura T, Kitamura Y, Biggs WH 3rd, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell. 2003
    連結:
  29. 1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 409:307-312, 2001
  30. 28. Martin A Jünger*, Felix Rintelen*†, Hugo Stocker*, Jonathan D Wasserman‡§, Mátyás Végh¶¥, Thomas Radimerski#, Michael E Greenberg‡ and Ernst Hafen* The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulinsignaling Journal of Biology 2003,